Searchable abstracts of presentations at key conferences in endocrinology

ea0050p264 | Neuroendocrinology and Pituitary | SFEBES2017

Early post-operative morning serum cortisol measurement as a predictor of remission of Cushing's disease

Thoppuram Nithin , Mendoza Nigel , Nair Ramesh , Hatfield Emma , Meeran Karim , Martin Niamh

Background: Determining post-operative remission in Cushing’s disease is challenging. There is no consensus for the post-operative serum cortisol value which reliably predicts remission of Cushing’s disease following trans-sphenoidal surgery. Traditionally, an early post-operative serum cortisol of below 50 nmol/L has been used to predict remission, but achieving this is often at the expense of hypopituitarism.<p class="abst...

ea0050p264 | Neuroendocrinology and Pituitary | SFEBES2017

Early post-operative morning serum cortisol measurement as a predictor of remission of Cushing's disease

Thoppuram Nithin , Mendoza Nigel , Nair Ramesh , Hatfield Emma , Meeran Karim , Martin Niamh

Background: Determining post-operative remission in Cushing’s disease is challenging. There is no consensus for the post-operative serum cortisol value which reliably predicts remission of Cushing’s disease following trans-sphenoidal surgery. Traditionally, an early post-operative serum cortisol of below 50 nmol/L has been used to predict remission, but achieving this is often at the expense of hypopituitarism.<p class="abst...

ea0048cb10 | Additional Cases | SFEEU2017

A challenging case of dual endocrine pathology

Ramli Rozana , Steer Keith , Hatfield Emma , Mehta Amrish , Jones Brynn , Mendoza Nigel , Meeran Karim , Martin Niamh

A 39-year-old man presented with thyrotoxicosis and was diagnosed with Graves’ disease. Despite high doses of anti-thyroid medication for 18 months, he remained biochemically and clinically hyperthyroid. Therefore, a thyroidectomy was planned. Four days before surgery, he developed double vision and was referred for urgent Neurosurgical review at our centre. On further questioning, he reported a 12-month history of lethargy and low libido. On examination, he had right 6th...

ea0070ep291 | Pituitary and Neuroendocrinology | ECE2020

Cabergoline treatment: The ethics around side effects

Ratnasabapathy Risheka , Patel Bijal , Qayum Ambreen , Zaman Shamaila , Behary Preeshila , Meeran Karim , Martin Niamh

Cabergoline has long been used to treat prolactinomas for symptomatic, radiological and biochemical resolution of pituitary tumours. As clinicians we are well-versed at screening for physical side effects, but are we holistic enough? We present two cases illustrating the damaging social consequences of cabergoline treatment for prolactinomas.Case 1A 49-year-old married father of two presented with a seizure in April 2018. MRI showe...

ea0028p343 | Thyroid | SFEBES2012

Evaluation of adjuvant lithium treatment in patients receiving radioactive iodine for hyperthyroidism: a retrospective cohort study

Patel Miraj , Nijher Gurjinder , Misra Shivani , Murphy Elaine , Meeran Karim , Martin Niamh

Lithium increases retention of Iodine-131 in the thyroid gland and inhibits thyroid hormone release following radioactive iodine (RAI) administration. However, outcomes of studies of the effects of lithium on the efficacy of RAI are conflicting. The aim of this study was to assess whether adjuvant lithium increases the efficacy of RAI treatment in hyperthyroidism. A retrospective cohort study was performed of 204 hyperthyroid patients (163 Graves’ disease, 26 toxic multin...

ea0086p247 | Neuroendocrinology and Pituitary | SFEBES2022

Surgical management of prolactinomas in patients with dopamine agonist-associated impulse control disorders or who are deemed at ‘high risk’

T. C. Yu Arthur , Wernig Florian , Meeran Karim , Martin Niamh , Mendoza Nigel , Nair Ramesh , Jones Brynmor , Gontsarova Anastasia , Behary Preeshila

Introduction: Prolactinomas are the commonest type of secretory pituitary tumours. In current practice, dopamine agonists (DA) remain the mainstay treatment. However, treating physicians are increasingly aware of DA-associated impulse control disorders (ICD) in their patients. We describe 4 individuals with prolactinomas, who either developed ICD on DA or deemed at ‘high risk’, successfully managed surgically with preservation of pituitary function. All decisions for...

ea0086p352 | Neuroendocrinology and Pituitary | SFEBES2022

The heart bleeds – complex management of a patient with acromegaly, cardiomyopathy and mechanical mitral valve

Sharma Aditi , Nyunt Sandhi , Narula Kavita , Mitchell Catherine , Mendoza Nigel , Yong Yong , Hatfield Emma , Meeran Karim , Martin Niamh

A 44 year old gentleman presented to his local hospital with a two week history of fevers and rigors. Blood cultures were positive for Streptococcus oralis, and an echocardiogram confirmed new diagnosis of hypertrophic cardiomyopathy (HCM) complicated by mitral valve infective endocarditis (IE). Unfortunately, this required a mechanical mitral valve replacement (MVR) and he started warfarin (INR target 2.5-3.5). During his admission, he reported chronic headaches. An MRI brain...

ea0090ep759 | Pituitary and Neuroendocrinology | ECE2023

Endocrinopathy behind the facemask – follow up

Nyunt Sandhi , Sharma Aditi , Narula Kavita , Mitchell Catherine , Mendoza Nigel , Ling Yong Yong , Hatfield Emma , Meeran Karim , Martin Niamh

A 44-year-old gentleman presented to the Emergency Department with a 2-week history of fever and rigors. Past medical history was unremarkable other than an earlier diagnosis of hypertension. He was noted to have new onset atrial fibrillation with rapid ventricular response; a diagnosis of hypertrophic obstructive cardiomyopathy (HOCM) was made on echocardiography. In addition, a vegetation was identified on the mitral valve. Treatment for infective endocarditis (Streptoco...

ea0038p316 | Pituitary | SFEBES2015

Does basal post-operative early morning cortisol measurement predict HPA axis integrity as assessed by an insulin tolerance test in patients who have undergone pituitary surgery?

Ahmad Syed Mustafa Ali , Papadopoulou Debbie , Hatfield Emma , Mendoza Nigel , Nair Ramesh , Meeran Karim , Martin Niamh M

Background: Correct identification of patients with HPA axis dysfunction following trans-sphenoidal pituitary surgery is important. Our centre measures post-operative day 5 0900 h serum cortisol (24 h after the last dose of glucocorticoid) to identify the need for glucocorticoid replacement. This is given if post-operative day 5 0900 h cortisol concentration is <300 nmol/l, until dynamic pituitary function assessment occurs.Methods: Data were reviewe...

ea0065p313 | Neuroendocrinology | SFEBES2019

Prolactinoma causing visual disturbance in pregnancy – a multidisciplinary management conundrum

Azam Sultana , Scott Rebecca , Izzi-Engbeaya Chioma , Jarvis Sheba , Samarasinghe Suhaniya , Comninos Alexander , Hill Neil , Ali Mahamoud Hassan , Nair Ramesh , Hatfield Emma , Martin Niamh , Martin Karim

A 33 year old primip presented to the local ophthalmic hospital at 34+4 weeks’ gestation with two weeks of blurred vision. Examination revealed a bitemporal hemianopia and reduced visual acuity. She was previously fit and well, and a pre-eclampsia screen was negative. An MRI scan demonstrated a haemorrhagic pituitary lesion extending into the suprasellar cistern with mild compression of the optic chiasm. Pituitary function tests showed a raised prolactin 3844 mU/l, isolat...